Compare BAL PHARMA with MEDICAMEN BI - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs MEDICAMEN BI - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA MEDICAMEN BI BAL PHARMA/
MEDICAMEN BI
 
P/E (TTM) x 52.9 56.5 93.7% View Chart
P/BV x 2.8 6.4 44.5% View Chart
Dividend Yield % 1.0 0.1 687.8%  

Financials

 BAL PHARMA   MEDICAMEN BI
EQUITY SHARE DATA
    BAL PHARMA
Mar-21
MEDICAMEN BI
Mar-21
BAL PHARMA/
MEDICAMEN BI
5-Yr Chart
Click to enlarge
High Rs73665 11.0%   
Low Rs29177 16.1%   
Sales per share (Unadj.) Rs169.092.2 183.3%  
Earnings per share (Unadj.) Rs3.29.9 32.0%  
Cash flow per share (Unadj.) Rs9.612.0 80.1%  
Dividends per share (Unadj.) Rs1.001.00 100.0%  
Avg Dividend yield %2.00.2 828.8%  
Book value per share (Unadj.) Rs35.5108.7 32.7%  
Shares outstanding (eoy) m14.8212.22 121.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.34.6 6.6%   
Avg P/E ratio x16.042.4 37.7%  
P/CF ratio (eoy) x5.335.1 15.1%  
Price / Book Value ratio x1.43.9 37.0%  
Dividend payout %31.510.1 312.3%   
Avg Mkt Cap Rs m7535,144 14.6%   
No. of employees `000NANA-   
Total wages/salary Rs m41990 465.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m2,5051,127 222.3%  
Other income Rs m118 150.9%   
Total revenues Rs m2,5171,135 221.8%   
Gross profit Rs m246197 125.3%  
Depreciation Rs m9525 377.8%   
Interest Rs m12215 804.1%   
Profit before tax Rs m41164 25.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-643 -14.3%   
Profit after tax Rs m47121 38.8%  
Gross profit margin %9.817.5 56.4%  
Effective tax rate %-14.926.0 -57.1%   
Net profit margin %1.910.8 17.5%  
BALANCE SHEET DATA
Current assets Rs m1,641960 170.9%   
Current liabilities Rs m1,525533 286.3%   
Net working cap to sales %4.637.9 12.2%  
Current ratio x1.11.8 59.7%  
Inventory Days Days115 197.4%  
Debtors Days Days979170,160,472 0.0%  
Net fixed assets Rs m759913 83.2%   
Share capital Rs m148122 121.3%   
"Free" reserves Rs m3781,207 31.3%   
Net worth Rs m5261,329 39.6%   
Long term debt Rs m23964 373.6%   
Total assets Rs m2,4011,940 123.7%  
Interest coverage x1.311.8 11.3%   
Debt to equity ratio x0.50 943.2%  
Sales to assets ratio x1.00.6 179.6%   
Return on assets %7.07.0 99.9%  
Return on equity %9.09.1 98.1%  
Return on capital %21.212.9 165.2%  
Exports to sales %60.072.2 83.1%   
Imports to sales %22.71.5 1,518.2%   
Exports (fob) Rs m1,504814 184.8%   
Imports (cif) Rs m56817 3,373.3%   
Fx inflow Rs m1,504814 184.8%   
Fx outflow Rs m58630 1,947.7%   
Net fx Rs m918784 117.1%   
CASH FLOW
From Operations Rs m218128 170.5%  
From Investments Rs m-50-178 28.0%  
From Financial Activity Rs m-16658 -284.8%  
Net Cashflow Rs m28 20.7%  

Share Holding

Indian Promoters % 42.5 44.8 94.7%  
Foreign collaborators % 4.4 0.0 -  
Indian inst/Mut Fund % 0.2 0.4 42.9%  
FIIs % 0.2 0.4 42.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.1 55.2 96.3%  
Shareholders   16,319 5,595 291.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   DIVIS LABORATORIES  CADILA HEALTHCARE  WOCKHARDT  GSK PHARMA  BERYL DRUGS  



Today's Market

Sensex Jumps 550 Points, Nifty Above 17,000; Metal & Banking Stocks Rally(10:30 am)

Asian stock markets are higher today as investors took heart from strong rebounds on Wall Street on hopes that the newest coronavirus variant will prove less virulent than earlier strains.

Related Views on News

MEDICAMEN BI 2020-21 Annual Report Analysis (Annual Result Update)

Nov 22, 2021 | Updated on Nov 22, 2021

Here's an analysis of the annual report of MEDICAMEN BI for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of MEDICAMEN BI. Also includes updates on the valuation of MEDICAMEN BI.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BAL PHARMA SHARE PRICE


Dec 7, 2021 01:26 PM

TRACK BAL PHARMA

  • Track your investment in BAL PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BAL PHARMA - IND SWIFT LA COMPARISON

COMPARE BAL PHARMA WITH

MARKET STATS